AG
BMY icon

AmeriFlex Group’s Bristol-Myers Squibb BMY Stock Holding History

AmeriFlex Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$686K Sell
11,913
-76
-0.6% -$4.36K 0.28% 70
2026
Q1 		$727K Buy
11,989
+1,751
+17% +$102K 0.37% 58
2025
Q4 		$552K Buy
10,238
+6,171
+152% +$297K 0.29% 72
2025
Q3 		$183K Buy
4,067
+2,936
+260% +$137K 0.07% 227
2025
Q2 		$52.8K Sell
1,131
-8,741
-89% -$429K 0.03% 376
2025
Q1 		$602K Buy
9,872
+4,409
+81% +$257K 0.25% 93
2024
Q4 		$322K Buy
+5,463
New +$305K 0.15% 140

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AmeriFlex Group's BMY Position: Q2 2026 in Review

AmeriFlex Group reduced its Bristol-Myers Squibb (BMY) stake by 0.63% in Q2 2026, selling an estimated $4.36K and leaving 11,913 shares worth $686K. The position accounts for 0.28% of the portfolio, ranked #70.

AmeriFlex Group first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $727K in Q1 2026. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • AmeriFlex Group held 11,913 shares of Bristol-Myers Squibb worth $686K as of Q2 2026.
  • AmeriFlex Group sold 76 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.36K.
  • Bristol-Myers Squibb made up 0.28% of AmeriFlex Group's portfolio in Q2 2026, its #70 holding.
  • AmeriFlex Group first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • AmeriFlex Group's Bristol-Myers Squibb position peaked at $727K in Q1 2026.
  • 2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.